ArticleImaging neuroscience (Cambridge, Mass.)2024
Creating diverse and inclusive scientific practices for research datasets and dissemination.
Article in Imaging neuroscience (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- External validation improves generalizability, replicability and reproducibility in predictive models for neuroimaging.Nature methods · 2026Review
- TheJournal of clinical and translational science · 2026Article
- Roadmap and Reflections on Expanding Equity, Diversity, Inclusion, Indigeneity, and Accessibility in Pharmacology Curricula.Pharmacology research & perspectives · 2025Article
- Bioethical and critical consciousness in clinical translational neuroscience.Journal of clinical and translational science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diversity, equity, and inclusivity (DEI) are important for scientific innovation and progress. This widespread recognition has resulted in numerous initiatives for enhancing DEI in recent years. Although progress has been made to address gender and racial disparities, there remain biases that limit the opportunities for historically under-represented researchers to succeed in academia. As members of the Organization for Human Brain Mapping (OHBM) Diversity and Inclusivity Committee (DIC), we identified the most challenging and imminent obstacles toward improving DEI practices in the broader neuroimaging field. These obstacles include the lack of diversity in and accessibility to publicly available datasets, barriers in research dissemination, and/or barriers related to equitable career advancements. In order to increase diversity and promote equity and inclusivity in our scientific endeavors, we suggest potential solutions that are practical and actionable to overcome these barriers. We emphasize the importance of the enduring and unwavering commitment required to advance DEI initiatives consistently. By doing so, the OHBM and perhaps other neuroscience communities will strive toward a future that is not only marked by scientific excellence but also characterized by diverse, inclusive, and equitable opportunities for all, including historically under-represented individuals around the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.